Prognostic implications in myelodysplastic syndromes: A review of 62 cases.

about

Prognostic implications in myelodysplastic syndromes: A review of 62 cases.

Item

http://www.wikidata.org/entity/Q41489340

description

1996 nî lūn-bûn

@nan

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

1996年论文

@zh

1996年论文

@zh-cn

name

Prognostic implications in myelodysplastic syndromes: A review of 62 cases.

@en

type

Item

label

Prognostic implications in myelodysplastic syndromes: A review of 62 cases.

@en

prefLabel

Prognostic implications in myelodysplastic syndromes: A review of 62 cases.

@en

P1476

Prognostic implications in myelodysplastic syndromes: A review of 62 cases.

@en

P2093

Fujita K

http://www.w3.org/2001/XMLSchema#string

Higuchi T

http://www.w3.org/2001/XMLSchema#string

Mori H

http://www.w3.org/2001/XMLSchema#string

Niikura H

http://www.w3.org/2001/XMLSchema#string

Omine M

http://www.w3.org/2001/XMLSchema#string

P2860

Proposals for the classification of the myelodysplastic syndromes

Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemia.

Dysmyelopoietic syndromes. A search for prognostic factors in 193 patients.

Prognostic factors in the myelodysplastic syndromes: importance of initial data on peripheral blood counts, bone marrow cytology, trephine biopsy and chromosomal analysis.

Defective neutrophil function and microbicidal mechanisms in the myelodysplastic disorders.

Extended cytogenetic follow-up of patients with myelodysplastic syndrome (MDS).

Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndrome: a survey by the Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG)

Prognostic features of chronic myelomonocytic leukaemia: a modified Bournemouth score gives the best prediction of survival.

Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. A phase I-II trial.

A phase II trial of recombinant human granulocyte colony-stimulating factor in the myelodysplastic syndromes.

P304

479-484

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428199609093447

http://www.w3.org/2001/XMLSchema#string

P433

5-6

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1996-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9172814

http://www.w3.org/2001/XMLSchema#string